These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1990570)

  • 21. Antithymocyte gamma globulin, low-dosage cyclosporine, and tapering steroids as an immunosuppressive regimen to avoid early kidney failure in heart transplantation.
    Deeb GM; Kolff J; McClurken JB; Dunn J; Balsara R; Ochs R; Badellino M; Hollander T; Eldridge C; Clancey M
    J Heart Transplant; 1987; 6(2):79-83. PubMed ID: 3305833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential use of antithymocyte globulin and cyclosporine augments skin allograft survival.
    Thomas J; Whitley T; Carver M; Thomas F
    Transplant Proc; 1984 Dec; 16(6):1522-4. PubMed ID: 6390858
    [No Abstract]   [Full Text] [Related]  

  • 23. Development of chronic renal cyclosporin-A toxicity.
    Klintmalm G
    Nephrologie; 1987; 8(3):131-3. PubMed ID: 3309701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclosporine: nursing and paraprofessional aspects.
    Transplant Proc; 1983 Dec; 15(4 Suppl 1-2):3109-83. PubMed ID: 6665864
    [No Abstract]   [Full Text] [Related]  

  • 25. Covariables in cyclosporine immunosuppression.
    Grevel J; Napoli KL; Kahan BD
    Transplant Proc; 1990 Jun; 22(3):1113-5. PubMed ID: 2349671
    [No Abstract]   [Full Text] [Related]  

  • 26. Deterioration in glucose metabolism in pancreatic transplant recipients after conversion from azathioprine to cyclosporine.
    Gunnarsson R; Klintmalm G; Lundgren G; Tydén G; Wilczek H; Ostman J; Groth CG
    Transplant Proc; 1984 Jun; 16(3):709-12. PubMed ID: 6375038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of toxic side effects of cyclosporine in heart transplantation.
    Schüler S; Warnecke H; Hetzer R
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2518-21. PubMed ID: 3547936
    [No Abstract]   [Full Text] [Related]  

  • 28. Cardiac transplantation with cyclosporine and steroids: medium and long-term results.
    Hakim M; Spiegelhalter D; English TA; Caine N; Wallwork J
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):327-32. PubMed ID: 3291264
    [No Abstract]   [Full Text] [Related]  

  • 29. Cyclosporine A administration: once a day or in fractional doses?
    Dieperink H; Leyssac PP; Starklint H; Kemp E
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):703-6. PubMed ID: 3284118
    [No Abstract]   [Full Text] [Related]  

  • 30. Nephrotoxicity of a nonionic (iopamidol) versus an ionic (diatrizoate) contrast agent in the patient after cardiac transplant with moderate cyclosporine-induced renal insufficiency.
    Denys BG; Reddy PS; Uretsky BF
    Am J Cardiol; 1989 Aug; 64(5):405-6. PubMed ID: 2667306
    [No Abstract]   [Full Text] [Related]  

  • 31. Conversion of immunosuppression in renal allograft recipients from cyclosporine A to azathioprine and prednisolone 6 months after transplantation.
    Lennard TW; Venning M; Donnelly PK; Wilson RG; Parrott NR; Elliott RW; Proud G; Farndon JR; Ward MK; Wilkinson R
    Transplant Proc; 1987 Oct; 19(5):3594-6. PubMed ID: 3313866
    [No Abstract]   [Full Text] [Related]  

  • 32. Is cyclosporine A-induced nephrotoxicity in recipients of renal allografts progressive?
    Thiel G; Mihatsch M; Landmann J; Hermle M; Brunner FP; Harder F
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):169-78. PubMed ID: 3895657
    [No Abstract]   [Full Text] [Related]  

  • 33. A brief course of cyclosporine A pretransplant reduces posttransplant cyclosporine A requirements in beagles and humans.
    Burke G; Esquenazi V; Milgrom M; Fuller L; Roth D; Olson L; Miller J
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):478-80. PubMed ID: 3363650
    [No Abstract]   [Full Text] [Related]  

  • 34. Renal consequences of a low dose cyclosporine triple therapy regimen in cardiac transplantation.
    Bennett WM; Hosenpud J; Pantley G; Cobanoglu A; Starr A; Norman DJ
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2479-80. PubMed ID: 2650308
    [No Abstract]   [Full Text] [Related]  

  • 35. Case presentations in renal transplantation.
    Kahan BD
    Transplant Proc; 1989 Jun; 21(3 Suppl 1):70-96. PubMed ID: 2662537
    [No Abstract]   [Full Text] [Related]  

  • 36. Triple and quadruple therapy after renal transplantation in patients from developing countries.
    Slapak M; Shell T; Digard N; Gosling DC; Qerchi della Rovera G; Crockett RC; Ahmed K
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1922-5. PubMed ID: 3547896
    [No Abstract]   [Full Text] [Related]  

  • 37. Cyclosporine provides better success rates for both higher- and lower-risk cadaveric kidney transplant recipients.
    Feduska NJ; Melzer JS; Amend WJ; Vincenti F; Tomlanovich SJ; Garovoy M; Husing R; Salvatierra O
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):102-9. PubMed ID: 3291212
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of the safety and efficacy of oral vs constant-rate intravenous infusion cyclosporine immediately following orthotopic heart transplantation.
    Myre SA; Schroeder TJ; Melvin DB; Pesce AJ; Collins JA; Stephens GW; First MR
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2484-6. PubMed ID: 2650310
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of five cyclosporine-prednisone regimens for induction of immunosuppression in cadaveric kidney recipients: a retrospective analysis of 245 cases.
    Kahan BD; Lorber MI; Flechner SM; Van Buren CT; Jensen C; Wideman CA
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):59-65. PubMed ID: 3515696
    [No Abstract]   [Full Text] [Related]  

  • 40. Cyclosporine A and hypertension.
    Schachter M
    J Hypertens; 1988 Jul; 6(7):511-6. PubMed ID: 3049794
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.